home · filing · 0001193125-21-227378
8-K filed July 28, 2021, 7:59 PM ET
ticker CRBU
CIK 0001619856
other material
confidence high
sentiment positive
materiality 0.85
Caribou Biosciences completes $304M IPO; sells 19M shares at $16 each
Caribou Biosciences, Inc.
Gross proceeds of $304M before underwriting discounts; underwriters have 30-day option for up to 2.85M additional shares.
All outstanding preferred stock (Series A, A-1, B, C) converted into 26,234,654 common shares automatically prior to IPO close.
Director Jeffrey Long-McGie resigned effective July 27, 2021, in connection with the IPO closing; no disagreement cited.
Adopted 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan; entered amended employment agreements with four named officers.
Filed amended and restated certificate of incorporation and bylaws effective July 27, 2021.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-07-27
Filed July 28, 2021, 7:59 PM ET
Effective as of July 27, 2021, Mr. Jeffrey Long-McGie resigned from the Company’s board of directors in connection with the closing of the Offering.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jeffrey Long-McGie resigned as Director at Caribou Biosciences, Inc..
Action resigned
Role Director
Exact text from the filing
Effective as of July 27, 2021, Mr. Jeffrey Long-McGie resigned from the Company’s board of directors in connection with the closing of the Offering.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-21-227378
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.